JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Other Versions of this Article:
JVI.02327-06v1
81/12/6326    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kummer, M.
Right arrow Articles by Prechtel, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kummer, M.
Right arrow Articles by Prechtel, A. T.
Journal of Virology, June 2007, p. 6326-6338, Vol. 81, No. 12
0022-538X/07/$08.00+0     doi:10.1128/JVI.02327-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Herpes Simplex Virus Type 1 Induces CD83 Degradation in Mature Dendritic Cells with Immediate-Early Kinetics via the Cellular Proteasome{triangledown} ,{dagger}

Mirko Kummer,1 Nadine M. Turza,1 Petra Muhl-Zurbes,1 Matthias Lechmann,1,{ddagger} Chris Boutell,2 Robert S. Coffin,3,4 Roger D. Everett,2 Alexander Steinkasserer,1 and Alexander T. Prechtel1*

Department of Dermatology, University Hospital Erlangen, Erlangen, Germany,1 MRC Virology Unit, Institute of Virology, University of Glasgow, Church St., Glasgow G11 5JR, Scotland, United Kingdom,2 Department of Immunology and Molecular Pathology, University College London, London W1P 6DB, United Kingdom,3 BioVex Ltd., Oxford OX14 4RX, United Kingdom4

Received 24 October 2006/ Accepted 29 March 2007

Mature dendritic cells (DCs) are the most potent antigen-presenting cells within the human immune system. However, Herpes simplex virus type 1 (HSV-1) is able to interfere with DC biology and to establish latency in infected individuals. In this study, we provide new insights into the mechanism by which HSV-1 disarms DCs by the manipulation of CD83, a functionally important molecule for DC activation. Fluorescence-activated cell sorter (FACS) analyses revealed a rapid downmodulation of CD83 surface expression within 6 to 8 h after HSV-1 infection, in a manner strictly dependent on viral gene expression. Soluble CD83 enzyme-linked immunosorbent assays, together with Western blot analysis, demonstrated that CD83 rapidly disappears from the cell surface after contact with HSV-1 by a mechanism that involves protein degradation rather than shedding of CD83 from the cell surface into the medium. Infection experiments with an ICP0 deletion mutant demonstrated an important role for this viral immediate-early protein during CD83 degradation, since this particular mutant strain leads to strongly reduced CD83 degradation. This hypothesis was further strengthened by cotransfection of plasmids expressing CD83 and ICP0 into 293T cells, which led to significantly reduced accumulation of CD83. In strong contrast, transfection of plasmids expressing CD83 and a mutant ICP0 defective in its RING finger-mediated E3 ubiquitin ligase function did not reduce CD83 expression. Inhibition of the proteasome, the cellular protein degradation machinery, almost completely restored CD83 surface expression during HSV-1 infection, indicating that proteasome-mediated degradation and HSV-1 ICP0 play crucial roles in this novel viral immune escape mechanism.


* Corresponding author. Mailing address: Department of Dermatology, University Hospital Erlangen, Hartmannstrasse 14, D-91052 Erlangen, Germany. Phone: 49-9131-853-3873. Fax: 49-9131-853-6417. E-mail: alexander.prechtel{at}derma.imed.uni-erlangen.de

{triangledown} Published ahead of print on 11 April 2007.

{dagger} Supplemental material for this article may be found at http://jvi.asm.org/.

{ddagger} Present address: Princess Margaret Hospital, Toronto, Ontario, Canada M5G 2C1.


Journal of Virology, June 2007, p. 6326-6338, Vol. 81, No. 12
0022-538X/07/$08.00+0     doi:10.1128/JVI.02327-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.